[{"from": "human", "value": "Could you provide a description of this molecule? [C][C][=C][Branch2][Ring1][Branch2][C][=C][C][=Branch1][Branch1][=C][Ring1][=Branch1][Cl][O][C][C][N][C][C][N][Branch1][Branch1][C][C][Ring1][=Branch1][C][C][=C][Branch2][Branch1][#Branch1][S][C][=N][C][=N][C][=Branch1][=Branch1][=C][Ring1][=Branch2][Ring1][=Branch1][O][C@H1][Branch2][Ring1][S][C][C][=C][C][=C][C][=C][Ring1][=Branch1][O][C][C][=N][C][=Branch1][=Branch1][=N][C][=C][Ring1][=Branch1][C][=C][C][=C][C][=C][Ring1][=Branch1][C][O][C][=Branch1][C][=O][O][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][F]"}, {"from": "gpt", "value": "The molecule is an inhibitor of induced myeloid leukemia cell differentiation protein (Mcl-1; Bcl2-L-3), with potential pro-apoptotic and antineoplastic activities. Upon administration, MIK665 binds to and inhibits the activity of Mcl-1, which promotes apoptosis of cells overexpressing Mcl-1. Mcl-1, an anti-apoptotic protein belonging to the Bcl-2 family of proteins, is upregulated in cancer cells and promotes tumor cell survival."}]